TRAF2 and cancer: Mutations and aberrant DNA methylation are known to cause dysregulation of gene expression in cancer (Nishiyama and Nakanishi, 2021), and our findings are consistent with previous studies (Hill et al., 2020; Moon et al., 2021), indicating TRAF2 has a high rate of gene mutations.